Adagene ADAG
NASDAQ ADAG
$3.58 -0.11 (-2.98%)
As of: Sep 4, 2026 · 3:59 PM EDT

Adagene (ADAG) Accounts Payables (2019 - 2026)

Adagene (ADAG) posted quarterly Accounts Payables of $2884.5 billion for Q4 2025, down 32.0% year-over-year from $4241.8 billion in Q4 2024, and up 79545669.8% quarter-over-quarter from $3.6 million in Q2 2025.

Analysis

Adagene (ADAG) Accounts Payables (2019 - 2026) Analysis & Trends

Adagene (ADAG) has reported Accounts Payables for 7 consecutive years, with $2884.5 billion the latest figure, recorded in Q4 2025.

  • In Q4 2025, Accounts Payables fell 32.0% year-over-year to $2884.5 billion; the TTM figure through Dec 2025 stood at $2884.5 billion (down 32.0% YoY), while the FY2025 annual figure was $2884.5 billion, down 32.0% from the prior year.
  • Accounts Payables rose to $2884.5 billion in Q4 2025 per ADAG's latest filing, from $3.6 million in the prior quarter.
  • Across five years, Accounts Payables topped out at $4665.9 billion in Q2 2022 and bottomed at $2.8 million in Q2 2021.
  • Historically, Accounts Payables has averaged $2303.6 billion across 5 years, with a median of $2989.1 billion in 2023.
  • Annual changes were most pronounced in 2022 — Accounts Payables surged 164640507.15% — and 2024, when it sank 100.0%.
  • Adagene's Accounts Payables stood at $3.3 million in 2021, then surged by 110371631.82% to $3666.1 billion in 2022, then slipped by 15.61% to $3093.8 billion in 2023, then surged by 37.11% to $4241.8 billion in 2024, then sank by 32.0% to $2884.5 billion in 2025.
  • Business Quant data shows ADAG's Accounts Payables at $2884.5 billion in Q4 2025, $3.6 million in Q2 2025, and $4241.8 billion in Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 429.50 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 1.16 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 1.52 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 167.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 88.42 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 470.30 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 108.02 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 35.57 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 428.93 Mn
10 Adagene 211.24 Mn 211.24 Mn - 15.54 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 15.54 Mn
Dec 31, 2025 2.88 Mn
Jun 30, 2025 3.63 Mn
Dec 31, 2024 4.24 Mn
Jun 30, 2024 3.37 Mn
Dec 31, 2023 3.09 Mn
Jun 30, 2023 4.48 Mn
Dec 31, 2022 3.67 Mn
Jun 30, 2022 4.67 Mn
Dec 31, 2021 3.32 Mn
Jun 30, 2021 2.83 Mn
Dec 31, 2020 1.81 Mn
Dec 31, 2019 712,714.00